Cargando…
Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
Introduction: Coronaviruses encode a helicase that is essential for viral replication and represents an excellent antiviral target. However, only a few coronavirus helicase inhibitors have been patented. These patents include drug-like compound SSYA10-001, aryl diketo acids (ADK), and dihydroxychrom...
Autores principales: | Spratt, Austin N., Gallazzi, Fabio, Quinn, Thomas P., Lorson, Christian L., Sönnerborg, Anders, Singh, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074651/ https://www.ncbi.nlm.nih.gov/pubmed/33593200 http://dx.doi.org/10.1080/13543776.2021.1884224 |
Ejemplares similares
-
Infectivity of SARS-CoV-2: there Is Something More than D614G?
por: Kannan, Saathvik R., et al.
Publicado: (2020) -
Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
por: Spratt, Austin N., et al.
Publicado: (2021) -
Continued Complexity of Mutations in Omicron Sublineages
por: Spratt, Austin N., et al.
Publicado: (2022) -
Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
por: Kannan, Saathvik R., et al.
Publicado: (2022) -
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
por: Singh, Kamal, et al.
Publicado: (2019)